Eli Lilly (NYSE:LLY) reported quarterly earnings of $2.62 per share which beat the analyst consensus estimate of $2.13 by 23 percent. This is a 40.11 percent increase over earnings of $1.87 per share from the same period last year. The company reported quarterly sales of $7.81 billion which beat the analyst consensus estimate of $6.68 billion by 16.92 percent. This is a 14.76 percent increase over sales of $6.81 billion the same period last year.
Aclarion Has Received A Notice Of Allowance For Its U.S. Patent Application 16/224,590 Titled “Magnetic Resonance Spectroscopy System And Method For Diagnosing Pain Or Infection Associated With Propionic Acid” – Patent Center
https://patentcenter.uspto.gov/applications/16224590/ifw/docs
